1. Home
  2. SGMT vs DENN Comparison

SGMT vs DENN Comparison

Compare SGMT & DENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMT
  • DENN
  • Stock Information
  • Founded
  • SGMT 2006
  • DENN 1953
  • Country
  • SGMT United States
  • DENN United States
  • Employees
  • SGMT N/A
  • DENN N/A
  • Industry
  • SGMT
  • DENN Restaurants
  • Sector
  • SGMT
  • DENN Consumer Discretionary
  • Exchange
  • SGMT Nasdaq
  • DENN Nasdaq
  • Market Cap
  • SGMT 238.7M
  • DENN 265.2M
  • IPO Year
  • SGMT 2023
  • DENN 1989
  • Fundamental
  • Price
  • SGMT $8.30
  • DENN $4.08
  • Analyst Decision
  • SGMT Strong Buy
  • DENN Buy
  • Analyst Count
  • SGMT 8
  • DENN 5
  • Target Price
  • SGMT $26.88
  • DENN $5.45
  • AVG Volume (30 Days)
  • SGMT 651.1K
  • DENN 837.6K
  • Earning Date
  • SGMT 11-13-2025
  • DENN 11-03-2025
  • Dividend Yield
  • SGMT N/A
  • DENN N/A
  • EPS Growth
  • SGMT N/A
  • DENN N/A
  • EPS
  • SGMT N/A
  • DENN 0.30
  • Revenue
  • SGMT N/A
  • DENN $455,727,000.00
  • Revenue This Year
  • SGMT N/A
  • DENN $7.62
  • Revenue Next Year
  • SGMT N/A
  • DENN $1.92
  • P/E Ratio
  • SGMT N/A
  • DENN $13.91
  • Revenue Growth
  • SGMT N/A
  • DENN 0.06
  • 52 Week Low
  • SGMT $1.73
  • DENN $2.85
  • 52 Week High
  • SGMT $11.41
  • DENN $7.73
  • Technical
  • Relative Strength Index (RSI)
  • SGMT 54.70
  • DENN 31.11
  • Support Level
  • SGMT $8.02
  • DENN $4.86
  • Resistance Level
  • SGMT $9.46
  • DENN $5.35
  • Average True Range (ATR)
  • SGMT 0.62
  • DENN 0.26
  • MACD
  • SGMT 0.07
  • DENN -0.11
  • Stochastic Oscillator
  • SGMT 45.67
  • DENN 0.78

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

About DENN Denny's Corporation

Denny's Corp is America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees. Geographically operates in USA states as well as globally like Canada, Mexico, Guatemala, Indonesia, United Kingdom, New Zealand and others. Maximum revenue is from USA and Canada.

Share on Social Networks: